Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be…
Read MoreTwo-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be…
Read MoreThe coronavirus pandemic has made vaccines from Pfizer/BioNTech and Moderna and the mRNA technology that they use into household names. These types of jabs are new but researchers have been working for…
Read MoreThe Thai hashtag #PfizerForStudents became the top-trending hashtag on Twitter in Thailand for two consecutive days, which resulted in a fiery debate on why some students, dubbed as the Thai…
Read More(Reuters) – The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID–19 vaccine – the first to secure such Food and Drug Administration validation – prompting President Joe Biden to make a fresh pitch to vaccine skeptics…
Read MoreLONDON (Reuters) – Two doses of Pfizer or AstraZeneca‘s COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed. Officials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that…
Read MoreThailand’s purchase contract for 20 million doses of Pfizer-BioNTech vaccine has been signed, with delivery expected in the fourth quarter of this year, according to Pfizer and BioNTech today (Tuesday)….
Read MoreA Malaysian coronavirus vaccination center was temporarily closed Tuesday after more than 200 workers tested positive for Covid-19, authorities said, as the country’s cases set a new daily record. The…
Read MoreMANILA, June 20 (Reuters) – The Philippine government has signed a supply agreement for 40 million doses of the COVID-19 vaccine developed by Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE), the head of…
Read MoreHong Kong may soon have to throw away millions of Coronavirus vaccine doses because they are approaching their expiry date and not enough people have signed up for the jabs,…
Read MoreThe head of Pfizer said in an interview aired Thursday that people will “likely” need a third dose of his company’s Covid-19 shot within six to 12 months of vaccination,…
Read MorePfizer/BioNTech’s coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies. Using data…
Read More(Reuters) – New Zealand started its official rollout of Pfizer-BioNTech’s COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus…
Read MoreThe US green lighted the Pfizer-BioNTech Covid-19 vaccine late Friday, paving the way for its imminent rollout across the country, with President Donald Trump promising the first immunizations would take…
Read MorePage 1 of 1